TCL Archive Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer September 26, 2003
TCL Archive Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue). May 9, 2003
TCL Archive BCDDP Follow Up To Cost $1.6 Million annually For Five Years Okayed; Limited To 59,000 Women November 3, 1978